Our Purpose
Serious chronic diseases today are often treated with chronic therapies. For patients with diseases such as hemophilia, type 1 diabetes or lysosomal storage disorders, this amounts to less than ideal clinical outcomes combined with frequent injections and infusions — sometimes multiple times daily — and constant, lifelong vigilance to manage their disease.
There is a better way. At Sigilon we are pioneering Shielded Living Therapeutics™ as a novel treatment for a wide range of chronic diseases. Shielded Living Therapeutics™ can recapitulate, restore and replace many natural biological functions.